(Q46721352)

24 December 2017

title

Fluoroquinolone-associated dysglycemias: a tale of two toxicities (English)

1 reference

24 December 2017

author name string

Robert C Owens

series ordinal

1

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

24 December 2017

published in

Pharmacotherapy

1 reference

24 December 2017

volume

25

1 reference

24 December 2017

issue

10

1 reference

24 December 2017

page(s)

1291-1295

1 reference

24 December 2017

A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1291

Hypoglycemia in inpatients after gatifloxacin or levofloxacin therapy: nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1291

Timing of new black box warnings and withdrawals for prescription medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1291

Hypoglycemia in hospitalized nondiabetic older patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1291

Hypoglycemia as a predictor of mortality in hospitalized elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1291

Hypoglycaemia in elderly patients with diabetes mellitus: causes and strategies for prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1291

Evaluation of the extent of under-reporting of serious adverse drug reactions: the case of toxic epidermal necrolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1291

Effect of multiple-dose gatifloxacin or ciprofloxacin on glucose homeostasis and insulin production in patients with noninsulin-dependent diabetes mellitus maintained with diet and exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1291

Profile of moxifloxacin drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1291

QT prolongation with antimicrobial agents: understanding the significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1291

Concomitant risk factors in reports of torsades de pointes associated with macrolide use: review of the United States Food and Drug Administration Adverse Event Reporting System

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1291

Torsades de pointes associated with fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1291

Gatifloxacin in community-based treatment of acute respiratory tract infections in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1291

ATP-sensitive K+ channels and insulin secretion: their role in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1291

Increase in insulin release from rat pancreatic islets by quinolone antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1291

Effects of fluoroquinolones on insulin secretion and beta-cell ATP-sensitive K+ channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1291

Gatifloxacin and the elderly: pharmacokinetic-pharmacodynamic rationale for a potential age-related dose reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1291

10.1592/PHCO.2005.25.10.1291

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017